PureTech Health PLC
PRTCBuild a strategy around PRTC
PureTech Health PLC AI Insights
Informational only. Not investment advice.Snapshot
- Net income of 50.7M TTM driven by 144M unusual items - core operations lost 118M at operating level[Total Unusual Items]
- Cash of 261M covers 2.1 years of operating burn (118M/yr) with minimal debt (21M) - runway secured[Cash and Equivalents]
- R&D of 40M TTM exceeds revenue (6.2M) by 6.5x - pre-commercial biotech dependent on pipeline monetization[Research and Development]
Watch Triggers
- Cash and Equivalents: Falls below 150M — Below 150M signals <18 months runway, forcing dilutive financing or fire-sale asset deals
- Total Revenue: Exceeds 25M quarterly — Would indicate pipeline commercialization inflection, shifting from asset-sale to recurring revenue model
- Special Income Charges: Drops to zero for 2+ quarters — Signals pipeline monetization pipeline exhausted, accelerating cash burn timeline
Bull Case
Fortress balance sheet (261M cash, 21M debt) funds 2+ years of R&D without dilution while 153M TTM special income proves ability to monetize pipeline assets
Trading near cash value (261M) with pipeline optionality - downside protected by liquid assets covering 47% of total assets
Bear Case
Core operations burning 118M/yr with only 6.2M revenue - requires continuous asset sales or dilution beyond 2027
Unusual items (144M) mask true losses - stripping one-time gains reveals unsustainable -94M pretax loss from operations
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage PRTC's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Pipeline monetization events will drive step-change in valuation over 1-3 years
- 153M special income TTM signals active asset monetization
- R&D spend 6.5x revenue indicates late-stage pipeline
- Net investment sales of 140M shows portfolio harvesting
Valuation Context
Caveats
Public Strategies Rankings
See how PureTech Health PLC ranks across different investment strategies.
Leverage PRTC's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
PRTC Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$442.81M | — | ||
$203.12M | — | ||
11 | — | ||
$6.17M | — | ||
$1.70 | — | ||
-1,908% | -1907.7% | — | |
822% | +821.9% | — | |
$-100.31M | — | ||
14.7% | +34.5% | — | |
Beta 5Y (Monthly) | unknown | — |
PRTC Dividend History
PRTC Stock Splits
PRTC SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
06/30/25 | 06/30/25 | 6-K | |
04/30/25 | 12/31/24 | Unknown | |
06/30/24 | 06/30/24 | 6-K | |
04/25/24 | 12/31/23 | 20-F | |
06/30/23 | 06/30/23 | 6-K | |
04/28/23 | 12/31/22 | 20-F | |
06/30/22 | 06/30/22 | 6-K | |
04/26/22 | 12/31/21 | 20-F | |
06/30/21 | 06/30/21 | 6-K | |
04/15/21 | 12/31/20 | 20-F | |
06/30/20 | 06/30/20 | Unknown | -- |
04/09/20 | 12/31/19 | Annual | -- |
06/30/19 | 06/30/19 | Unknown | -- |
04/24/19 | 12/31/18 | Annual | -- |
06/30/18 | 06/30/18 | Unknown | -- |
04/16/18 | 12/31/17 | Annual | -- |
06/30/17 | 06/30/17 | Unknown | -- |
04/06/17 | 12/31/16 | Annual | -- |
06/30/16 | 06/30/16 | Unknown | -- |
04/07/16 | 12/31/15 | Annual | -- |
06/30/15 | 06/30/15 | Unknown | -- |
06/19/15 | 12/31/14 | Annual | -- |